ARCHIVES

CMS Considering Regulatory Standards for Drug Company Bundling of Products.

This article is from The Cancer Letter archive.

Vol. 32 No. 37 | October 20, 2006

Download PDF Visit The Full Archive

Related Articles

An Earmark In The Making? NCI Urged to Boost Gastric Cancer Funding

December 17, 2013

Pitot Supports Clearinghouse Modifications

January 20, 1978

FDA Oncology Division To Develop Papers On Expectations for New Drugs

August 2, 1996

Finasteride Could Save Many Years Of Life If Widely Used For Prostate Cancer Prevention

February 25, 2005

In Congress: Senate Resolution Includes $15 Billion For NIH In FY99

April 10, 1998

32% Rise In Breast Cancer Diagnosis In 1980s Explained By Increase In Mammography Screening

September 21, 1990